Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. The Rotterdam Eye Hospital

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Rotterdam Eye Hospital (Het Oogziekenhuis), located at Schiedamse Vest 180, 3011 BH Rotterdam, Netherlands, is the country's leading specialist center for ophthalmology and its largest provider of ophthalmic care. Established in 1874, the hospital operates out of a historic, Italian palazzo-style building completed in 1948 by architect Ad van der Steur, which has since been designated a municipal monument. Renowned globally for its patient-centered approach and medical innovation, the hospital pioneered the "time-out" safety procedure in Dutch healthcare, offers unique operational features like valet parking to alleviate patient anxiety, and co-founded the World Association of Eye Hospitals (WAEH). Alongside its clinical facility, the hospital houses the Rotterdam Ophthalmic Institute (ROI), serving as the largest educational and research hub for ophthalmologists in the Netherlands while maintaining cutting-edge research partnerships with institutions like Erasmus MC

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Eye care center

Business Subcategory

Source: Human-provided. Eye care center
Source: Human-provided. Specialized hospital
Source: Trial-derived.
6Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
2Active Trials
Source: Trial-derived.
3Completed Trials
Source: Trial-derived.
8Unique Conditions
Source: Trial-derived.
10Unique Sponsors

Conditions

Source: Trial-derived. Geographic Atrophy (2)Source: Trial-derived. Amblyopia (1)Source: Trial-derived. Amblyopia, Anisometropic (1)Source: Trial-derived. Amblyopia Strabismic (1)Source: Trial-derived. Chronic Central Serous Chorioretinopathy (1)Source: Trial-derived. Macular Degeneration (1)Source: Trial-derived. Non-infectious Uveitis (1)Source: Trial-derived. Usher Syndrome, Type 1B (1)

Sponsors

Source: Trial-derived. Janssen Research & Development, LLC (2)Source: Trial-derived. Oogziekenhuis Rotterdam (2)Source: Trial-derived. Elisabeth-TweeSteden Ziekenhuis (1)Source: Trial-derived. Fondazione Telethon (1)Source: Trial-derived. Health Holland (1)Source: Trial-derived. Jeroen Bosch Ziekenhuis (1)Source: Trial-derived. Panoptes Pharma GmbH (1)Source: Trial-derived. Radboud University Medical Center (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. Optical coherence tomography (OCT)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravitreal injection

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Fundus autofluorescence imaging
Source: AI-inferred. Mesopic microperimetry
Source: AI-inferred. Periocular corticosteroid injection
Source: AI-inferred. Radner reading-speed testing